Nu Skin Enterprises Crecimiento futuro

Future controles de criterios 3/6

Se prevé que los ingresos de Nu Skin Enterprises disminuyan en un 2.6% al año, mientras que se espera que sus beneficios anuales crezcan en un 74.1% al año. Se prevé que el BPA crezca en un 74.1% anual. Se prevé que la rentabilidad financiera sea de 8.5% en 3 años.

Información clave

74.1%

Tasa de crecimiento de los beneficios

74.1%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Personal Products	21.4%
Tasa de crecimiento de los ingresos	-2.6%
Rentabilidad financiera futura	8.5%
Cobertura de analistas	Low
Última actualización	23 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Capital Allocation Trends At Nu Skin Enterprises (NYSE:NUS) Aren't Ideal

Mar 28

Nu Skin: A Sell Signal Amidst Industry Decline And Strategic Uncertainty

Mar 04

We Think You Can Look Beyond Nu Skin Enterprises' (NYSE:NUS) Lackluster Earnings

Feb 22

Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be Reduced To $0.06

Feb 19

Analysts Just Shaved Their Nu Skin Enterprises, Inc. (NYSE:NUS) Forecasts Dramatically

Feb 18

Is Nu Skin Enterprises, Inc. (NYSE:NUS) Expensive For A Reason? A Look At Its Intrinsic Value

Jul 31

Nu Skin: A High-Risk/High-Reward Turnaround Play Worth The Risks

Jun 26

Is Now The Time To Look At Buying Nu Skin Enterprises, Inc. (NYSE:NUS)?

Jun 23

We Think Nu Skin Enterprises (NYSE:NUS) Is Taking Some Risk With Its Debt

May 22

Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.39

May 07

Nu Skin Enterprises (NYSE:NUS) Could Be Struggling To Allocate Capital

Apr 26

Why Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Worth Watching

Mar 18

Nu Skin Enterprises (NYSE:NUS) Will Pay A Larger Dividend Than Last Year At $0.39

Feb 19

Nu Skin raises quarterly dividend by 1.3% to $0.39/share

Feb 15

These 4 Measures Indicate That Nu Skin Enterprises (NYSE:NUS) Is Using Debt Reasonably Well

Feb 12

Returns On Capital At Nu Skin Enterprises (NYSE:NUS) Paint A Concerning Picture

Jan 25

Is Now The Time To Look At Buying Nu Skin Enterprises, Inc. (NYSE:NUS)?

Dec 04

Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.385

Nov 17

Nu Skin: Sell On The Pullback

Oct 06

Returns On Capital Signal Tricky Times Ahead For Nu Skin Enterprises (NYSE:NUS)

Sep 27

Nu Skin Enterprises (NYSE:NUS) Is Due To Pay A Dividend Of $0.385

Aug 24

Nu Skin Enterprises (NYSE:NUS) Has Affirmed Its Dividend Of $0.385

Aug 08

What Does Nu Skin Enterprises, Inc.'s (NYSE:NUS) Share Price Indicate?

Jul 24

Are Investors Undervaluing Nu Skin Enterprises, Inc. (NYSE:NUS) By 33%?

Jul 10

Previsiones de crecimiento de beneficios e ingresos

NYSE:NUS - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2025	1,870	73	60	125	3
12/31/2024	1,813	49	34	99	3
12/31/2023	1,969	9	60	119	N/A
9/30/2023	2,003	59	38	90	N/A
6/30/2023	2,042	70	2	67	N/A
3/31/2023	2,102	77	18	78	N/A
12/31/2022	2,226	105	49	108	N/A
9/30/2022	2,377	38	129	192	N/A
6/30/2022	2,480	113	142	194	N/A
3/31/2022	2,624	139	108	168	N/A
12/31/2021	2,696	147	73	142	N/A
9/30/2021	2,770	230	61	127	N/A
6/30/2021	2,833	237	143	215	N/A
3/31/2021	2,741	219	227	291	N/A
12/31/2020	2,582	191	315	379	N/A
9/30/2020	2,417	158	272	334	N/A
6/30/2020	2,304	146	204	270	N/A
3/31/2020	2,315	150	183	255	N/A
12/31/2019	2,420	174	112	178	N/A
9/30/2019	2,520	116	136	217	N/A
6/30/2019	2,606	125	154	225	N/A
3/31/2019	2,686	129	124	196	N/A
12/31/2018	2,679	122	132	203	N/A
9/30/2018	2,662	158	197	261	N/A
6/30/2018	2,550	146	210	270	N/A
3/31/2018	2,396	137	223	280	N/A
12/31/2017	2,279	129	242	303	N/A
9/30/2017	2,144	149	N/A	246	N/A
6/30/2017	2,185	165	N/A	223	N/A
3/31/2017	2,235	167	N/A	299	N/A
12/31/2016	2,208	143	N/A	275	N/A
9/30/2016	2,249	141	N/A	266	N/A
6/30/2016	2,216	100	N/A	298	N/A
3/31/2016	2,176	100	N/A	245	N/A
12/31/2015	2,247	133	N/A	322	N/A
9/30/2015	2,284	144	N/A	337	N/A
6/30/2015	2,352	196	N/A	288	N/A
3/31/2015	2,442	171	N/A	178	N/A
12/31/2014	2,569	189	N/A	-56	N/A
9/30/2014	3,016	268	N/A	-105	N/A
6/30/2014	3,285	311	N/A	156	N/A
3/31/2014	3,306	365	N/A	299	N/A
12/31/2013	3,177	365	N/A	530	N/A
9/30/2013	2,672	299	N/A	556	N/A
6/30/2013	2,290	242	N/A	331	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (74.1% al año) de NUS es superior a la tasa de ahorro (2.3%).

Beneficios vs. Mercado: Se prevé que los beneficios (74.1% al año) de NUS crezcan más rápidamente que el mercado US (14.7% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de NUS crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos de NUS disminuyan en los próximos 3 años (-2.6% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos de NUS disminuyan en los próximos 3 años (-2.6% al año).

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de NUS sea baja dentro de 3 años (8.5%).

Nu Skin Enterprises Crecimiento futuro

Future controles de criterios 3/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Consensus revenue estimates fall by 11%

Price target decreased by 26% to US$15.50

Consensus EPS estimates fall by 31%

Consensus EPS estimates fall by 32%

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2023

Price target decreased by 12% to US$27.75

Recent updates

Now 23% undervalued after recent price drop

Nu Skin Enterprises, Inc., Annual General Meeting, Jun 05, 2024

Now 21% undervalued after recent price drop

Nu Skin Enterprises, Inc. to Report Q1, 2024 Results on May 08, 2024

Capital Allocation Trends At Nu Skin Enterprises (NYSE:NUS) Aren't Ideal

Nu Skin: A Sell Signal Amidst Industry Decline And Strategic Uncertainty

We Think You Can Look Beyond Nu Skin Enterprises' (NYSE:NUS) Lackluster Earnings

Consensus revenue estimates fall by 11%

Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be Reduced To $0.06

Analysts Just Shaved Their Nu Skin Enterprises, Inc. (NYSE:NUS) Forecasts Dramatically

Price target decreased by 26% to US$15.50

Fourth quarter dividend reduced to US$0.06

Full year 2023 earnings: EPS misses analyst expectations

Nu Skin Enterprises, Inc. Declares Quarterly Cash Dividend, Payable on March 6, 2024

Nu Skin Enterprises, Inc. Declares Quarterly Cash Dividend, Payable on March 6, 2024

Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Riskier Than It Looks

Consensus EPS estimates fall by 31%

Nu Skin Enterprises, Inc. to Report Q4, 2023 Results on Feb 14, 2024

Consensus EPS estimates fall by 32%

Nu Skin Enterprises (NYSE:NUS) Has A Somewhat Strained Balance Sheet

Nu Skin Enterprises (NYSE:NUS) Has Affirmed Its Dividend Of $0.39

Upcoming dividend of US$0.39 per share at 8.8% yield

Independent Director recently sold US$272k worth of stock

Independent Director notifies of intention to sell stock

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2023

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Nu Skin Enterprises, Inc. Announces Quarterly Dividend, Payable on December 6, 2023

Price target decreased by 12% to US$27.75

Nu Skin: Is It Just A Growth Problem?

Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company

Nu Skin Enterprises, Inc. to Report Q3, 2023 Results on Nov 01, 2023

Independent Director notifies of intention to sell stock

When Should You Buy Nu Skin Enterprises, Inc. (NYSE:NUS)?

Nu Skin: Attractive Valuation Trumps Near-Term Risks

Nu Skin Enterprises (NYSE:NUS) Takes On Some Risk With Its Use Of Debt

Independent Director recently sold US$146k worth of stock

Upcoming dividend of US$0.39 per share at 6.4% yield

Now 21% undervalued after recent price drop

Nu Skin Enterprises (NYSE:NUS) Has Announced A Dividend Of $0.39

Price target decreased by 22% to US$31.50

Nu Skin Enterprises, Inc. Provides Earnings Outlook for the Third Quarter and Full-Year 2023

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Nu Skin Enterprises, Inc. Announces Quarterly Dividend, Payable on September 6, 2023

Is Nu Skin Enterprises, Inc. (NYSE:NUS) Expensive For A Reason? A Look At Its Intrinsic Value

Nu Skin Enterprises, Inc. Appoints James D. Thomas as Chief Financial Officer

Nu Skin Enterprises, Inc. to Report Q2, 2023 Results on Aug 01, 2023

Nu Skin Enterprises, Inc. to Report Q2, 2023 Results on Aug 01, 2023

Nu Skin: A High-Risk/High-Reward Turnaround Play Worth The Risks

Nu Skin Enterprises, Inc.(NYSE:NUS) dropped from Russell 2000 Growth Index

Is Now The Time To Look At Buying Nu Skin Enterprises, Inc. (NYSE:NUS)?

We Think Nu Skin Enterprises (NYSE:NUS) Is Taking Some Risk With Its Debt

Upcoming dividend of US$0.39 per share at 4.2% yield

Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.39

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Second Quarter and Full Year Ended March 31, 2023

Nu Skin Enterprises Announces Quarterly Dividend, Payable on June 7, 2023

Nu Skin Enterprises (NYSE:NUS) Could Be Struggling To Allocate Capital

Why Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Worth Watching

President exercised options and sold US$329k worth of stock

Chief Accounting Officer recently sold US$116k worth of stock

Nu Skin Enterprises (NYSE:NUS) Will Pay A Larger Dividend Than Last Year At $0.39

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Nu Skin Enterprises, Inc. Announces Dividend Increase, Payable on March 8, 2023

Nu Skin raises quarterly dividend by 1.3% to $0.39/share

These 4 Measures Indicate That Nu Skin Enterprises (NYSE:NUS) Is Using Debt Reasonably Well

Returns On Capital At Nu Skin Enterprises (NYSE:NUS) Paint A Concerning Picture

Nu Skin Enterprises, Inc. to Report Q4, 2022 Results on Feb 15, 2023

Is Now The Time To Look At Buying Nu Skin Enterprises, Inc. (NYSE:NUS)?

Nu Skin Enterprises, Inc.(NYSE:NUS) dropped from S&P 400 Consumer Staples (Sector)